EICHORCondition: Carcinoma, Ovarian Epithelial · Ovarian Neoplasms · Ovarian Cancer · Sponsor: CanariaBio Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Study to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of subjects with newly diagnosed advanced ovarian cancer who have undergone optimal debulking.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Honor Health | Phoenix, Arizona, United States | — |
| The University of Arizona Cancer Center | Tucson, Arizona, United States | — |
| John Muir Health Clinical Research Center | Concord, California, United States | — |
| Kaiser Permanente Southern California | Irvine, California, United States | — |
| Moores UC San Diego Cancer Center | La Jolla, California, United States | — |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | — |
| Epic Care | Pleasant Hill, California, United States | — |
| Kaiser Permanente Riverside Medical Center | Riverside, California, United States | — |
| University of California, Davis Comprehensive Cancer Center | Sacramento, California, United States | — |
| Contra Costa Oncology | Walnut Creek, California, United States | — |
| John Muir Health Gynecologic Cancer Services | Walnut Creek, California, United States | — |
| University of Colorado Health | Aurora, Colorado, United States | — |
+ 136 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04498117